Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial
Jay H. Traverse, Timothy D. Henry, Stephen G. Ellis, Carl J. Pepine, James T. Willerson, David X.M. Zhao, John R. Forder, Barry J. Byrne, Antonis K. Hatzopoulos, Marc S. Penn, Emerson C. Perin, Kenneth W. Baran, Jeffrey Chambers, Charles Lambert, Ganesh Raveendran, Daniel I. Simon, Douglas E. Vaughan, Lara M. Simpson, Adrian P. Gee, Doris A. TaylorChristopher R. Cogle, James D. Thomas, Guilherme V. Silva, Beth C. Jorgenson, Rachel E. Olson, Sherry Bowman, Judy Francescon, Carrie Geither, Eileen Handberg, Deirdre X. Smith, Sarah Baraniuk, Linda B. Piller, Catalin Loghin, David Aguilar, Sara Richman, Claudia Zierold, Judy Bettencourt, Shelly L. Sayre, Rachel W. Vojvodic, Sonia I. Skarlatos, David J. Gordon, Ray F. Ebert, Minjung Kwak, Lemuel A. Moyé, Robert D. Simari
Research output: Contribution to journal › Article › peer-review
334Scopus
citations
Fingerprint
Dive into the research topics of 'Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial'. Together they form a unique fingerprint.